23/12/2011
1
Multiplex real-time PCR on faeces samples
Philippe Van Lint
Klinisch Laboratorium GZA dept. Moleculaire Diagnostiek
2
Causes of Gastroenteritis?
3
PROTOZOA 1) Giardia lamblia
2) Cryptosporidium spp.
3) Entamoeba histolytica
4
PROTOZOA
1) Giardia lamblia
• High prevalence (5-10%)
• Acute and chronic diarrhea
• Symptoms: diarrhea, stomach complaints, nausea, …
5
1) Giardia lamblia
6
23/12/2011
2
7
• High prevalence (+/- 4%)
• Diarrhea 2 - 4 weeks, disappears spontaneously (immuno-competent)
• Heavy cramps and watery diarrhea
less often: nausea, vomiting, fever,…
• Sometimes asymptomatic
2) Cryptosporidium spp.
8
• many outbreaks in waterparks, daycare centres,
community swimming pools…
2) Cryptosporidium spp.
Park Spoor Noord Antwerpen
9
• many outbreaks in waterparks, daycare centres,
community swimming pools…
• 1993 Milwaukee: infected water purification plant
• >400,000 people ill
• 104 deaths
2) Cryptosporidium spp.
10
2) Cryptosporidium spp.
11
3) Entamoeba histolytica
• Rare in Belgium
• Mainly immigrants & returning travellers from (sub)tropics
• Asymptomatic � invasive (amoebic dysentery, liver abscess, lethal…)
• Microscopically indistinguishable from E. dispar (non-pathogenic)
12
3) Entamoeba histolytica
23/12/2011
3
13
TECHNIQUES
14
MICROSCOPY
• Dependent on skills and knowledge
• Majority of sample are negative in our population
• Laborintensive
• Lower sensitivity: multiple samples should ideally be screened
• No discrimination E. histolytica / E. dispar
• Not limited to targeted parasites
• Cheap
15
PCR
• Superior sensitivity
• Very specific: eg. non-pathogenic E. dispar scores negative
• Less labor intensive (automation)
• Limited to parasites targeted
• Higher cost
16
Setup
Multiplex PCR: Green Cryptosporidium spp.
Red PhHV (IC)
Yellow E. histolytica
Orange Giardia lamblia
17
PCR optimization
18
Pretreatment:
• Take 300-600mg sample
• Add double volume buffer
• Disrupt w/o beads (Disruptor Genie)
• Centrifuge• Freeze supernatans at -80°C (o/n vs. 10min)
Optimization: pre treatment
PCR reaction:
• Different mastermixes
• Addition BSA
• Primer/probe concentrations
• Multiplex vs. monoplex
23/12/2011
4
19
Test validation
20
• Gel electroforesis
• Sequencing
• Intra- & interrun variability
• Sensitivity/specificity
Validation:
o Faecal samples screened by both PCR as well as microscopy
0,00%
0,50%
1,00%
1,50%
2,00%
2,50%
3,00%
3,50%
4,00%
4,50%
5,00%
G. lamblia Cryptosporidium
spp.
E. histolytica
Microscopy
Real-time PCR
21
• 631 samples tested by both methods
PCR Microscopy
Giardia lamblia 29 (4,7%) 11 (1,8%)
Cryptosporidium spp. 3 (0,5%) 1 (0,2%)
E. histolytica 0 (0,0%) 0 (0,0%)
Negative 581 (94,8%) 601 (98,0%)
• 18 samples showed PCR inhibition (=2,9%)
Ct PhHV (IC) >Average +2SD
All 18 scored negative on microscopy (omitted)
Sorry, confidential data
22
• Especially low positives (high Ct) are missed by microscopy: • Ct value significantly higher in those samples missed by microscopy
0,00
5,00
10,00
15,00
20,00
25,00
30,00
35,00
40,00
Ct
va
lue
Microscopy neg
Microscopy pos
25,4 +/-5,4 vs. 19,22 +/- 3,0
p<0,005
Sorry, confidential data
23
• Discrepant results screened in other lab starting from primary sample
PCR GZA microscopy PCR Tilburg
1 0435-0727 Giardia negative Giardia
2 0437-0342 Giardia negative Giardia
3 0437-0465 Giardia negative Giardia
4 0437-0467 Giardia negative Giardia
5 0452-0883 Giardia negative Giardia
6 0474-0851 Giardia negative Giardia
7 0495-1036 Cryptosporidium negative Cryptosporidium
8 0394-0527 Giardia Entamoeba coli Giardia
9 0394-0526 Giardia Entamoeba coli Giardia
10 1032-1221 Giardia negative Giardia
11 1032-1222 Giardia negative Giardia
12 1032-1223 Giardia negative Giardia
13 1062-0913 Giardia negative Giardia
14 1084-1122 Giardia negative Giardia
151113-0777 Giardia negative Giardia
16 1113-0785 Giardia negative Giardia
17 1137-0426 Giardia negative Giardia
18 1145 -1171 Cryptosporidium negative Cryptosporidium
19 1171- 0300 Giardia negative Giardia
20 1167-0416 Giardia negative Giardia
21 1205-0491 negative Giardia negative
24
• Two patient populations are defined
No travel history
andImmuno-competent
Patients with a travel history
and/or
immuno-compromised
PCR
PCR + microscopy
Actual implementation
23/12/2011
5
Lay-out request form
26
Conclusions
• Detection of parasites in faeces by automated DNA extraction and real-time PCR is feasible
• The sensitivity is superior to that of microscopy
• Microscopy remains necessary for a specific subset of patients
27
Acknowledgements GZA St-Augustinus
Axel JeurissenHilde De HenauLinda Verstraeten
Anneleen De Muynck
St-Elisabeth, Tilburg (NL)
John RossenHarold Verbakel
Lab Infectieziekten, Groningen (NL)
Mirjam Kooistra-Smid Richard de Boer
Qiagen
Walter van der VlietRob Peters
ITG, Antwerpen
Marjan Van EsbroeckLieselotte Cnops